{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T15:10:32Z","timestamp":1790521832520,"version":"4.1.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,11,20]]},"DOI":"10.1001\/jama.2018.14283","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T01:55:21Z","timestamp":1540432521000},"page":"1998","source":"Crossref","is-referenced-by-count":169,"title":["Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury"],"prefix":"10.1001","volume":"320","author":[{"given":"Peter","family":"Pickkers","sequence":"first","affiliation":[{"name":"Department of Intensive Care Medicine, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra L.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Diego, Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Murray","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joannidis","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Intensive Care and Emergency Medicine, Medical University Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A.","family":"Molitoris","sequence":"additional","affiliation":[{"name":"Indiana University, Indianapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Kellum","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Bachler","sequence":"additional","affiliation":[{"name":"Department of General and Surgical Critical Care Medicine, Medical University Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A. J.","family":"Hoste","sequence":"additional","affiliation":[{"name":"Intensive Care, Ghent University, Ghent, Belgium"},{"name":"Clinical Research Foundation Flanders, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Hoiting","sequence":"additional","affiliation":[{"name":"Intensive Care, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Krell","sequence":"additional","affiliation":[{"name":"Internal Medicine, Eastern Idaho Regional Medical Center, Idaho Falls"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies","family":"Ostermann","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 Hospital, King\u2019s College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Rozendaal","sequence":"additional","affiliation":[{"name":"Intensive Care, Jeroen Bosch Hospital, \u2018s-Hertogenbosch, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Valkonen","sequence":"additional","affiliation":[{"name":"Division of Anesthesia and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brealey","sequence":"additional","affiliation":[{"name":"Division of Critical Care, University College London Hospitals National Institute for Health Research Biomedical Research Centre, London, United Kingdom"},{"name":"Bloomsbury Institute of Intensive Care Medicine, University College Hospital, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus","family":"Beishuizen","sequence":"additional","affiliation":[{"name":"Intensive Care, Medisch Spectrum Twente, Enschede, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Meziani","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Service de R\u00e9animation, Universit\u00e9 de Strasbourg, H\u00f4pitaux Universitaires de Strasbourg, Nouvel H\u00f4pital Civil, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavan","family":"Murugan","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Center for Critical Care Nephrology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde","family":"de Geus","sequence":"additional","affiliation":[{"name":"Department of Intensive Care, Erasmus Medical Centre, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Payen","sequence":"additional","affiliation":[{"name":"Unit\u00e9 Mixte de Recherche INSERM 1160, University Paris 7 Denis Diderot, Paris, France"},{"name":"Department of Anaesthesiology and Critical Care, H\u00f4pital Lariboisi\u00e8re, Assistance Publique\u2014H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Clinical Department, AM-Pharma BV, Bunnik, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Arend","sequence":"additional","affiliation":[{"name":"Clinical Department, AM-Pharma BV, Bunnik, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the STOP-AKI Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"9887","key":"joi180110r1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","article-title":"Acute kidney injury: an increasing global concern.","volume":"382","author":"Lameire","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"joi180110r2","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"issue":"3","key":"joi180110r3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1164\/rccm.201505-0995OC","article-title":"The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock.","volume":"193","author":"Kellum","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"joi180110r4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease.","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney Int"},{"issue":"1","key":"joi180110r5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/SHK.0000000000000052","article-title":"A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury.","volume":"41","author":"Gomez","year":"2014","journal-title":"Shock"},{"issue":"6","key":"joi180110r6","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00134-017-4832-y","article-title":"Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.","volume":"43","author":"Joannidis","year":"2017","journal-title":"Intensive Care Med"},{"issue":"6","key":"joi180110r7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0009-9120(02)00330-2","article-title":"Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation.","volume":"35","author":"Koyama","year":"2002","journal-title":"Clin Biochem"},{"issue":"15","key":"joi180110r8","doi-asserted-by":"publisher","first-page":"13468","DOI":"10.1074\/jbc.M300569200","article-title":"Ecto 5'-nucleotidase and nonspecific alkaline phosphatase: 2 AMP-hydrolyzing ectoenzymes with distinct roles in human airways.","volume":"278","author":"Picher","year":"2003","journal-title":"J Biol Chem"},{"issue":"1-4","key":"joi180110r9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1159\/000363256","article-title":"The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injury.","volume":"127","author":"Peters","year":"2014","journal-title":"Nephron Clin Pract"},{"issue":"2","key":"joi180110r10","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/CCM.0b013e31819598af","article-title":"Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.","volume":"37","author":"Heemskerk","year":"2009","journal-title":"Crit Care Med"},{"issue":"1","key":"joi180110r11","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/cc11159","article-title":"Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial.","volume":"16","author":"Pickkers","year":"2012","journal-title":"Crit Care"},{"issue":"2","key":"joi180110r12","doi-asserted-by":"publisher","first-page":"e89374","DOI":"10.1371\/journal.pone.0089374","article-title":"Catalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potential.","volume":"9","author":"Kiffer-Moreira","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"joi180110r13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2015.08.090","article-title":"Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase.","volume":"495","author":"Peters","year":"2015","journal-title":"Int J Pharm"},{"key":"joi180110r14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.taap.2016.10.015","article-title":"Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in 2 models of acute kidney injury.","volume":"313","author":"Peters","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"issue":"9","key":"joi180110r15","doi-asserted-by":"publisher","first-page":"e012371","DOI":"10.1136\/bmjopen-2016-012371","article-title":"Study protocol for a multicentre randomised controlled trial: Safety, tolerability, efficacy and quality of life of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury (STOP-AKI).","volume":"6","author":"Peters","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"joi180110r16","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"issue":"2","key":"joi180110r17","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/cc5713","article-title":"Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.","volume":"11","author":"Mehta","year":"2007","journal-title":"Crit Care"},{"issue":"9","key":"joi180110r18","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1177\/0962280216684528","article-title":"Clinical dose-response for a broad set of biological products: a model-based meta-analysis.","volume":"27","author":"Wu","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"joi180110r19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/ki.2013.378","article-title":"Reading between the (guide)lines\u2014the KDIGO practice guideline on acute kidney injury in the individual patient.","volume":"85","author":"Okusa","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"joi180110r20","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00134-014-3641-9","article-title":"Comparison of different equations to assess glomerular filtration in critically ill patients.","volume":"41","author":"Carlier","year":"2015","journal-title":"Intensive Care Med"},{"issue":"3","key":"joi180110r21","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/cc11391","article-title":"Four-hour creatinine clearance is better than plasma creatinine for monitoring renal function in critically ill patients.","volume":"16","author":"Pickering","year":"2012","journal-title":"Crit Care"},{"issue":"5","key":"joi180110r22","first-page":"393","article-title":"Minimum urine collection periods for accurate determination of creatinine clearance in critically ill patients.","volume":"6","author":"Baumann","year":"1987","journal-title":"Clin Pharm"},{"issue":"9843","key":"joi180110r23","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury.","volume":"380","author":"Bellomo","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"joi180110r26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ki.1985.205","article-title":"Limitations of creatinine as a filtration marker in glomerulopathic patients.","volume":"28","author":"Shemesh","year":"1985","journal-title":"Kidney Int"},{"issue":"10","key":"joi180110r27","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","article-title":"Serum creatinine as an index of renal function: new insights into old concepts.","volume":"38","author":"Perrone","year":"1992","journal-title":"Clin Chem"},{"issue":"6","key":"joi180110r28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1164\/rccm.201604-0799OC","article-title":"Recovery after acute kidney injury.","volume":"195","author":"Kellum","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"joi180110r29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneph.2017.184","article-title":"Paradigms of acute kidney injury in the intensive care setting.","volume":"14","author":"Kellum","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"joi180110r30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1681\/ASN.2015030309","article-title":"Progression after AKI: understanding maladaptive repair processes to predict and identify therapeutic treatments.","volume":"27","author":"Basile","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"joi180110r31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis.","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"issue":"1-4","key":"joi180110r32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000363725","article-title":"Clinical trial endpoints in acute kidney injury.","volume":"127","author":"Billings","year":"2014","journal-title":"Nephron Clin Pract"},{"issue":"6","key":"joi180110r33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1053\/j.ajkd.2013.11.027","article-title":"Alkaline phosphatase: a possible treatment for sepsis-associated acute kidney injury in critically ill patients.","volume":"63","author":"Peters","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"6 Pt 2","key":"joi180110r34","first-page":"F849","article-title":"Effect of reversible and irreversible ischemia on marker enzymes of BBM from renal cortical PT subpopulations.","volume":"273","author":"Khundmiri","year":"1997","journal-title":"Am J Physiol"},{"issue":"20","key":"joi180110r35","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.1111\/bph.13261","article-title":"Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate.","volume":"172","author":"Peters","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"10","key":"joi180110r36","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s40262-016-0399-y","article-title":"Pharmacokinetic modeling and dose selection in a randomized, double-blind, placebo-controlled trial of a human recombinant alkaline phosphatase in healthy volunteers.","volume":"55","author":"Peters","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"joi180110r24","unstructured":"National Kidney Foundation. CKD-EPI creatinine equation (2009). https:\/\/www.kidney.org\/content\/ckd-epi-creatinine-equation-2009. Accessed October 17, 2018."},{"key":"joi180110r25","unstructured":"Acute Kidney Injury Network. AKIN studies. http:\/\/www.akinet.org\/akinstudies.php. Accessed October 17, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2710776","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T20:13:02Z","timestamp":1605298382000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.14283"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2018,11,20]]},"references-count":36,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,11,20]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.14283","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,20]]}}}